Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
130
NCT04704258
NAUTILUS CE-mark Trial of the FLOWer Cerebral Embolic Protection Device
Phase: N/A
Role: Lead Sponsor
Start: May 3, 2021
Completion: Jun 6, 2023
NCT05791071
Virtual Reality Intervention for Skill Acquisition Support in Autism Spectrum Disorder (ASD)
Phase: Phase 2
Role: Collaborator
Start: Feb 15, 2023
Completion: Jun 29, 2023